Sagimet Biosciences Announces Pricing of Upsized Initial Public Offering

Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT) today announced the pricing of its upsized initial public offering of 5,312,500 shares of its Series A common stock at a public offering price of $16.00 per share.

Scroll to Top